{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":1,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"16edabda8aab","filters":{"venue":"Sarcoma Research - International"}},"results":[{"id":"W3194091392","doi":"10.26420/sarcomaresint.2021.1047","title":"Real-World Outcomes of Advanced Soft Tissue Sarcoma Patients Treated with Pazopanib","year":2021,"lang":"en","type":"article","venue":"Sarcoma Research - International","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Pazopanib; Medicine; Soft tissue sarcoma; Sarcoma; Internal medicine; Oncology; Tyrosine-kinase inhibitor; Chemotherapy; Surgery; Soft tissue; Cancer; Sunitinib; Pathology","authors":[{"name":"A Fawaz","is_ca":true},{"name":"Insop Shim","is_ca":true},{"name":"D G Tilley","is_ca":true},{"name":"Kelaney MR","is_ca":false},{"name":"Abdelsalam OMA","is_ca":false},{"name":"Hatim Karachiwala","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04535030066170792,"gpt":0.3889955458283232,"spread":0.3436452451666153,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006819148,0.0001521582,0.0002311363,0.000614858,0.000354801,0.0008446428,0.0002838022,0.0002292244,0.001211],"category_scores_gemma":[0.002319048,0.00009592242,0.0002575846,0.001020393,0.0003555515,0.0004622077,0.0004651875,0.0004593593,0.0001984368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001099127,"about_ca_system_score_gemma":0.0007128049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005354627,"about_ca_topic_score_gemma":0.008197906,"domain_scores_codex":[0.9994625,0.0001453157,0.00006939301,0.00009732495,0.0001254458,0.0001000294],"domain_scores_gemma":[0.9970828,0.0002573486,0.001850059,0.00006619338,0.0002964859,0.0004471871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001909093,0.00002867073,0.9975999,0.00001225393,0.00003881419,0.00010093,0.00005863361,0.0001229108,0.00006882469,0.00001688194,0.0001756292,0.001585647],"study_design_scores_gemma":[0.00001850315,0.0002112334,0.9979197,0.000008865507,0.00003359598,0.0005654464,0.0002489953,0.000358259,0.00008501546,0.00003667295,0.0005066573,0.000006998214],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980845,0.0002512438,0.00006125408,0.00007335588,0.000004234052,0.00001411478,0.0008934607,0.000003118456,0.0006146848],"genre_scores_gemma":[0.9988239,0.0001012628,0.00004403431,0.00001680386,0.000007343946,0.000008358743,0.0009412342,0.000001119658,0.00005589135],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005354627,"threshold_uncertainty_score":0.01064688,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}